The site is replete with references to the AOD9604 obesity programme; its research, its prospects and its value to the company and investors that, to say the least, have been overtaken by events.
I look forward to seeing the website cleaned up, forward looking, and dealing forthrightly with the company's present situation.
Add to My Watchlist
What is My Watchlist?